Purpose of review Sepsis requires prompt recognition and aggressive therapy; early goal-directed therapy decreases morbidity and mortality. Recommendations on the specific management of pediatric sepsis have historically been extrapolated from adult literature and from expert/ consensus opinion. This review serves to appraise recent recommendations and determine the applicability of newly promoted adult guidelines for pediatric sepsis.
Introduction
The incidence of pediatric sepsis has been recently estimated to be 0.56/1000 children with the highest incidence in infancy at 5.6/1000; overall mortality is 10.6% [1] . Despite next-generation conjugate vaccines, rates of sepsis have not declined; this is likely because most sepsis occurs in infants prior to complete immunization. In fact, the rate of sepsis may increase due to the improved survival of immunocompromised and immunosuppressed children. Watson et al. [1] found that 49% of cases of sepsis in children had underlying illnesses, which place them at risk of higher morbidity and mortality. In the Children's Hospital of Pittsburg, the mortality rate for children who were previously healthy was 2% compared with 12% for children with chronic illness [2] .
Definitions
Specific pediatric definitions of sepsis were published in 2005; prior to this, previous definitions were adult-specific and extrapolated to children [3 •• ,4] . The systemic inflammatory response syndrome (SIRS) in pediatrics requires the presence of an abnormal temperature (hypothermia or hyperthermia) or leukocytosis, in the presence of one other criterion (abnormal temperature, leukocytosis, tachypnea, or tachycardia). Sepsis is defined as the proven or suspected infection in the setting of SIRS [3 •• ,4] . Severe sepsis is defined as sepsis in the setting of acute respiratory distress syndrome, cardiovascular organ dysfunction, or two or more other acute organ dysfunctions (respiratory, renal, hematologic, neurologic, or hepatic) [3 •• ] .
Septic shock is defined clinically as the presence of tachycardia and poor perfusion with or without hypotension, the latter being a marker of decompensated shock and not required to make the diagnosis of septic shock as in adults. The definition of hypotension will vary with age but is defined as a blood pressure less than the 5th percentile for age [5] . Septic shock is physiologically complex with pathologic vasodilation, relative or absolute hypovolemia, myocardial depression, altered blood flow distribution, and inhibition of cellular metabolism. It is sometimes characterized in terms of 'warm' shock or 'cold' shock in terms of perfusion, which correspond to peripheral vasodilation or vasoconstriction, respectively. Ceneviva et al. [6] showed that children with fluid-refractory shock can present in either of the above two ways, or with a combination of both vasodila-tion and poor cardiac output. In fact, in contrast to adults who usually present with high cardiac output and low vascular resistance, 78% of children showed some degree of cardiac dysfunction on presentation after fluid resuscitation. Furthermore, about 50% of patients required a change in their vasopressor or inotropic management, or addition of another agent, emphasizing that the hemodynamic status in children can change rapidly.
Management priorities
Management priorities include the need to:
(1) recognize and treat promptly the signs and symptoms of shock; (2) institute measures that support and maintain circulation; (3) support measures that counteract hypoxemia and impair tissue oxygenation; (4) maintain frequent reassessments to anticipate issues that may contribute to circulatory collapse, progression of shock, or insufficient therapy; (5) institute interventions that lead to identification of the source of infection and treat promptly for infection; (6) ensure prompt and expeditious transfer of care to a pediatric intensive care unit for continued hemodynamic monitoring and goal-directed therapy.
Although there have been no recent advances reported on the management of sepsis in children, the adult literature provides increasing evidence for early aggressive management. Specifically, goal-directed therapy is advocated in the first 6 h of presentation. Many of the strategies may be extrapolated to children and are reviewed below.
Initial management
As studies provide further evidence that the early normalization of hemodynamic status can have an effect on overall outcomes, the management of sepsis in the emergency department becomes ever more essential. Initial management should focus on interpreting and treating hemodynamic derangements, with targeted diagnostic and therapeutic interventions aimed at improving tissue perfusion and restoring a balance between oxygen delivery and demand. This initial management is what is called early goal-directed therapy, and some initial studies in adults have shown that early correction of the hemodynamic derangement leads to improved overall survival. Rivers et al. [7] showed in 263 adults that there is 33% less mortality in patients with sepsis (45.5% compared with 30.5%) when, within 6 h of presentation, the patient was aggressively approached with early fluid administration, early red-cell transfusions, and early inotropic therapy. Although laboratory studies rarely impact the management of septic shock in the first hour of therapy, patients should have laboratory studies sent routinely assessing for hematologic abnormalities, metabolic derangements, or electrolyte abnormalities that may contribute to morbidity. A peripheral white blood count may aid in the choice of broad-spectrum antibiotics whereas a hemoglobin and platelet count will help in assessing the need for early blood transfusion. A blood bank sample should be sent to prepare for any necessary transfusions. Electrolyte abnormalities are common in sepsis; recognition and treatment of metabolic abnormalities, such as hypoglycemia and hypocalcemia, will improve outcome. A disseminated intravascular coagulation panel, including prothrombin time, partial thromboplastin time, and fibrinogen, will help in assessing for severity of illness, if abnormalities exist, and will be helpful when deciding about invasive procedures. An arterial or venous blood gas will determine the adequacy of ventilation, oxygenation, and the severity of acidemia.
Volume resuscitation
Hypovolemia may be present in absolute terms or relative terms. Absolute hypovolemia may be due to a number of factors: increased insensible losses, such as due to excessive sweating, fever, increased respiratory rate; excessive fluid losses from diarrhea or vomiting; or from third spacing of fluids as in ascites or peripheral edema. Relative hypovolemia occurs due to vasodilation (capacitance vessels and dysregulation of small vasculature).
Choice of resuscitation fluids
There are no new data to suggest a difference in survival rates after resuscitation with colloids (blood products) compared with crystalloid fluids. The choice of fluid is less important than the volume of fluid administered, as the latter sustains cardiac preload, increases stroke volume, and improves oxygen delivery. Although colloids are preferred in Europe, crystalloids are more commonly used in North America [8] . It is well established that isotonic saline (0.9%) and lactated Ringer's can be used interchangeably, except in specific diseases such as Dengue fever where fluid resuscitation with lactated Ringer's has a longer time to recovery from shock [9, 10] . Both crystalloids and colloids, specifically packed red blood cells, have equal effects on improving stroke volume, and when they are titrated to the same level of filling pressure, each fully restores tissue perfusion to the same degree [9] .
Crystalloids
We consider the administration of isotonic crystalloid fluids to be the most appropriate first agent in the initial management of any patient with sepsis and shock. Additionally, there is an increasing concern that the administration of blood products may worsen mortality in the critically ill [11, 12] ; but no study has specifically studied this issue in sepsis. The initial volume infused should be 20 ml/kg and be administered over 5-10 min. Immediate reassessment must occur at the completion of this infusion for signs of improved perfusion using clinical criteria, such as reduction in heart rate and improvement in blood pressure, capillary refill, quality of pulses, and mental status. If the clinical signs of shock persist, another 20 ml/kg of isotonic fluid should be administered and repeated once more, so that a total of 60 ml/kg should have been administered in the initial 15-30 min.
Colloids
Several studies have looked at the role of colloids in the early management of septic shock [9, 11, [13] [14] [15] . In general, when crystalloids and colloids are titrated to the same level of filling pressure, roughly three times more crystalloid volume is needed than colloid to achieve the equivalent central venous pressure (CVP) [8] .
Human albumin
There is no literature to suggest that 5% albumin administration improved outcome in regards to sepsis mortality [16] . Albumin administration may be most useful in patients who are hypoalbuminemic. We currently do not recommend the routine administration of 5% albumin in sepsis, however.
Packed red blood cells
The optimal hemoglobin for patients in septic shock has not been established. In the early management of sepsis in adults, maintaining a hemoglobin of 7-9 g/dl in order to improve oxygen-carrying capacity will improve sepsis survival by improving tissue perfusion [17] . Red blood cell transfusion will increase oxygen carrying capacity without increasing oxygen consumption [18] [19] [20] . Adults with myocardial disease have decreased mortality when their hemoglobin is above 10 g/dl [21] ; however, this typically is not an issue in the pediatric patient with sepsis. Anemia in sepsis has been associated with increased mortality, but so has the administration of blood [12, 16] . The Society of Critical Care Medicine has recommended that hemoglobin concentrations be maintained at 8-10 g/dl with the understanding that there are limited data for this practice [22] .
As pediatric data are limited, it is appropriate to extrapolate from the adult literature of maximizing tissue oxygen delivery if there is evidence of poor tissue perfusion. Patients with cardiovascular disease, low cardiac output, severe arterial hypoxemia, severe mixed venous saturation, or persistent lactic acidosis may need higher hemoglobin or longer duration of transfusion requirements, despite lack of data to support this practice. Once tissue hypoperfusion, acute hemorrhage, or lactic acidosis has resolved, red-cell transfusions need to be administered only when the hemoglobin is less than 7.0 g/dl with a target goal of 8-10 g/dl [17, 22] . The empiric administration of blood products is not recommended due to risks associated with transfusions [17] , risk of isoimmunization, and the expense and inadvertent depletion of blood bank stores. In adults, there is an increased risk of mortality and morbidity that is directly proportional to the number of transfusions that a patient has received during their intensive care unit stay [12, 23] .
Complex starches
Complex starches are considered colloids and have been considered as alternatives to blood products. The complex starches, however, have been associated with undesirable effects. Hydroxyethyl starches have been shown to have effects on coagulation, with predominant exerting inhibitory effects on platelet aggregation, but the newer starches have less of an effect on coagulation [24] [25] [26] [27] . Hydroxyethyl starch (6%) has been associated with an increased rate of acute renal failure [28] . These synthetic products can be rather expensive and have not been shown to be consistently superior to current fluid strategies.
Fluid resuscitation end point
There is no clearly defined end point in fluid resuscitation in the absence of a measurement of CVP or signs of fluid overload; thus, we recommend the administration of 20 ml/kg of isotonic saline/lactated Ringer's as initial bolus; this may be repeated twice more (total 60 ml/kg) over 15-30 min as clinically indicated by the hemody-namic status. Fluid refractory shock is defined as the persistence of signs of shock after the administration of sufficient fluids to have achieved a CVP of 8-12 mmHg (if a central venous line is in place), and/or signs of fluid overload (such as hepatic congestion and/or pulmonary edema). If the patient still shows signs of shock, additional therapy such as vasopressors should be administered while diagnostic and therapeutic interventions are being performed. Success of adequate fluid resuscitation can be guided by additional parameters: invasive blood pressure monitoring, CVP, measurement of mixed venous oxygen saturation (SVO2), measurement of blood lactate, and urine output.
Adjuncts of success in resuscitation
The diagnosis of shock is made via clinical criteria but success in management can be supported by laboratory or monitoring data. Laboratory adjuncts that may help include a serum lactate or SVO2 measurement. An elevated serum lactate level suggests tissue is hypoperfused and thus undergoing anaerobic metabolism [29] [30] [31] , even in those who are not hypotensive. In children, in whom hypotension is a late sign of shock, the measure of lactate may indicate which patients should be treated more aggressively. Data from an adult study indicate that when the lactate level is greater than 4.0 mEq/l on presentation, overall mortality is reduced when the lactate decreased below 4.0 mEq/l during the first 6 h of therapy [32] .
The SVO2 is appropriately best measured at the level of the pulmonary artery and referred to as the mixed venous saturation; however, the central SVO2 obtained from the superior vena cava or right atrium will approximate the mixed venous saturation. The SVO2 can be used as a measure of the oxygen supply and demand balance; however, many parameters go into assessing its accuracy and validity, since it is also dependent on hemoglobin content and arterial oxygen saturation.
Sepsis is associated with an increased oxygen demand and thus increased extraction, which will lower a patient's SVO2. The SVO2 can also be affected by a depressed cardiac output due to sepsis. Normalizing the cardiac output will improve the SVO2 saturation. Finally, in sepsis, there may be abnormalities in oxygen extraction or utilization, predominantly disruption of the oxidative phosphorylation system as would be seen in cyanide poisoning, and an elevated SVO2 will be present. This latter example will result in severe metabolic acidosis. Even in the setting of a normal SVO2, other clinical data should be used to ensure that the resuscitative efforts have restored normal perfusion. Systems have been developed to monitor SVO2 continuously with sensors that are incorporated into pulmonary artery or central venous catheters; however, the size of the catheters and the relative inexperience in placing and interpreting these data limit their use.
Selecting a predefined cardiac output should not be the goal since the goal of resuscitation is to restore the normal balance between oxygen supply and demand. In fact, several studies using an above normal cardiac index as a goal failed to show an overall difference in outcome, and in fact, may be associated with an increased mortality [33] [34] [35] . Thus, this latter approach is not recommended.
Signs of improvement include:
(1) improvement in perfusion by examination; (a) improvement in the quality of pulses (centrally and peripherally); (b) capillary refill ≤ 2 s; (c) improvement in skin color and temperature; (d) improvement in mental status; (2) decreasing heart rate; (3) mean arterial pressure > 65 mmHg; (4) urine output > 1 ml/kg/h; (5) CVP 8-12 mmHg; (6) SVO2 > 70%; (7) lactate < 4.0 mEq/dl.
Vasopressor therapy
Varied hemodynamic derangements can exist in children with septic shock. Predominant vasodilatory shock, referred to as 'warm' shock, is associated with vasodilation and capillary leak, but normal or elevated good cardiac output, as evidenced by strong pulses, warm extremities, good capillary refill, and tachycardia. Twenty percent of children with sepsis present in this state [6] . In this example, using agents (vasopressors) that promote vasoconstriction would benefit the most, such as dopamine, norepinephrine, epinephrine, phenylephrine, or vasopressin. A predominantly poor cardiac output state, referred to as 'cold' shock, is most commonly associated with vasoconstriction as compensation, and this can contribute to an increased cardiac afterload. This high systemic vascular resistance is clinically evidenced by weak pulses, cool extremities, slow capillary refill, and hepatic and pulmonary congestion. Fifty-eight percent of children present in this state [6] . Using agents (inotropes with or without vasodilators) such as dobutamine, epinephrine, or milrinone would be most beneficial; careful assessment of inotropy, systemic vascular resistance and blood pressure after instituting vasopressor therapy will guide further management. A combination of vasodilatory and 'cold' shock manifesting with a low systemic vascular resistance and poor cardiac output can exist in 22% of children in shock [6] . Ancillary information, such as echocardiogram, CVP, and SVO2, can help define any of the above physiologic states and thus help guide therapy.
The study by Ceneviva et al. [6] supports the use of pulmonary artery catheters in catecholamine-resistant shock -defined as a persistent shock state despite two or more vasopressors and/or inotropes. Considering the technical expertise required and the risks associated with their placement, we feel that there is no role for pulmonary artery catheter placement during initial stabilization.
Dopamine
Vasopressors are required in shock unresponsive to initial fluid resuscitation. In pediatrics, the initial agent of choice has typically been dopamine. Dopamine has direct and indirect agonist effects on dopamine-receptors, alpha-receptors and beta-receptors on both the heart and the peripheral vasculature. Dopamine has the advantage that it can be administered peripherally and centrally with minimal concern of tissue damage if accidental extravasation occurs. Dopamine should be started as a continuous infusion at 3-5 μg/kg/min and titrated upward in increments of 2.5 μg/kg/min every 3-5 min until the goal of improved perfusion and/or blood pressure is achieved. Neonates may be more sensitive to the effects of dopamine so changes of 1-2 μg/kg/min may be appropriate. A blood pressure goal should be a mean arterial blood pressure (MAP) of 65 mmHg or better. We recommend a maximum dose of 20 μg/kg/min since doses higher than this may contribute to increased myocardial demand without much improvement in vasopressor activity. Dopamine-resistant shock is diagnosed after titration of dopamine to 20 μg/kg/min with the persistence of signs or symptoms of shock. If a CVL has not been placed by this time, it is strongly recommended, since the administration of dopamine closer to the heart may be more efficacious than administration through a peripheral intravenous line. In addition, a CVL will allow the measurement of CVP, SVO2 and lactate.
Once a patient has shown that he/she is refractory to dopamine, we recommend several interventions:
(1) assess the patient's hemoglobin; improving the hemoglobin to 8-10 g/dl may improve tissue oxygen; (2) measure CVP to assess intravascular volume status with the goal to achieve a CVP of 8-12 mmHg; (3) obtain an SVO2 once the hematocrit has been corrected and use this along with the clinical exam as a marker of cardiac output.
Dopamine-resistant shock → norepinephrine
One of the mechanisms of dopamine action is enhancement of endogenous catecholamine release. In severe sepsis states, presynaptic vacuoles may be depleted of norepinephrine, which may explain why dopamine may have diminished efficacy. Norepinephrine is typically the next agent for dopamine-refractory shock since it provides direct receptor activation predominantly at the alpha-receptor. Norepinephrine has beta 1 receptor activity as well, but via the alpha-receptor, it will significantly increase the mean arterial pressure with little change in the heart rate and contractility. Martin et al. [36] showed that norepinephrine in adult patients with septic shock was successful in 93% of patients in restoring hemodynamics compared with dopamine which was successful in only 31%. More importantly, those patients in whom dopamine failed to restore hemodynamics improved with norepinephrine. Although this study was not designed to have enough power to examine survival benefit, those who received norepinephrine had a 59% survival compared with 17% for dopamine. This comparison has not been made in children, and we still recommend dopamine as firstline therapy in sepsis. Once dopamine has not improved perfusion and/or blood pressure, however, then norepinephrine should be administered and the dopamine weaned.
A common myth about norepinephrine is that renal perfusion decreases; this may, in fact, be true in hypovolemic or hemorrhagic shock. In a dog model of endotoxic septic shock, however, norepinephrine infusion resulted in increased renal blood flow [37] . Similar studies were done in adults showing that in septic shock, urine output increased with initiation of norepinephrine [38] [39] [40] . Starting doses of norepinephrine are 0.05 μg/kg/min, with a maximum dose of 1-2 μg/kg/min, titrated in 0.05-0.1 μg/kg/min increments every 3-5 min, with a MAP goal of greater than 65 mmHg.
Phenylephrine and vasopressin
Phenylephrine and vasopressin are potent and specific arteriolar vasoconstrictors and there is currently no data in pediatric septic shock. Phenylephrine is an alpha-1 selective adrenergic agonist and thus offers no inotropy; thus, phenylephrine will markedly increase afterload and worsen cardiac dysfunction. Vasopressin may be considered for patients with refractory shock who, despite adequate fluid resuscitation, are on other highdose vasopressors. It is not currently recommended as replacement for dopamine or norepinephrine, however, since there have been few studies in adults or children for this indication. Just as with phenylephrine, vasopressin may significantly elevate afterload and compromise cardiac output. These agents may serve as adjuncts to vasopressor therapy in settings of vasodilation with high cardiac output.
Dobutamine
Myocardial dysfunction can be diagnosed clinically by poor perfusion, low SVO2, high lactate, and normal to elevated CVP. The diagnosis would be supported by echocardiography or use of a pulmonary artery catheter. A chest radiograph with an enlarged heart and alveolar congestion can also suggest cardiac dysfunction but a normal cardiac silhouette is often present despite severe myocardial dysfunction. Children with low cardiac output states may benefit from dobutamine, which is the first agent of choice to improve cardiac output. Dobutamine is a nonselective beta adrenergic agonist, thus causing improved inotropy (contractility), chronotropy (increased rate), and some lusitropy (improved myocardial relaxation); however, its beta-2 activity can lead to peripheral vasodilation, and this must be considered prior to its use in a patient who may already be hypotensive. If hypotension does exist, it should be used in combination with other vasopressor therapy. Thus, dobutamine should be considered in the patient who has signs, symptoms, or laboratory values consistent with poor tissue perfusion, but has an adequate blood pressure to tolerate some degree of vasodilation. Dobutamine should be initiated at rates of 2.5 μg/kg/min and titrated in increments of 2.5 μg/kg/min every 3-5 min. Careful attention should be placed on monitoring the blood pressure. Improved perfusion, decreased lactate, and increased SVO2 will help determine appropriate dosing.
Epinephrine
Epinephrine is the second agent considered to improve cardiac output in patients with septic shock. It is a potent vasopressor with greater beta-1 adrenergic activity than norepinephrine, but as a result can cause an increased myocardial demand, tachycardia, and tachyarrhythmias. It can serve as an adjunct to existing therapy to improve mean arterial blood pressure and inotropy. A disadvantage of epinephrine is that it can have variable effects on splanchnic blood flow in septic patients, which may lead to mesenteric ischemia. The starting dose of epinephrine is 0.05 μg/kg/min, with a maximum dose of 2 μg/kg/min, titrated in 0.05-0.1 μg/kg/min increments every 3-5 min. The MAP goal is greater than 65 mmHg and the parameters described for dobutamine in regard to cardiac output should be used.
Vasodilators
The addition of a vasodilator, such as nitroprusside or nitroglycerin, can reverse shock in pediatric patients who have high systemic vascular resistances (SVR) by reducing afterload, again assuming the blood pressure is adequate to allow peripheral vasodilation. These are considered the agents of choice in children with epinephrine-resistant low cardiac output who remain hemodynamically unstable with a high SVR [6, 41] .
Phosphodiesterase inhibitors
Amirone and milrinone have little role in the management of septic shock in pediatric patients in the emergency department. Their half-life can be long, in the span of 2-3 h, longer in neonates, and as a result, are not easily titratable agents. Their predominant mechanism of action is thought to be through inhibition of phosphodiesterase, which is responsible for the breakdown of cyclic adenosine monophosphate (cAMP). Increased intracellular cAMP leads to improved cardiac contractility and relaxation. In the peripheral vasculature, an increase in cAMP results in vasodilation. There has been one study in pediatrics using milrinone in septic shock which showed that cardiac index and stroke volume improved significantly with little change in heart rate, so it may have a role as an adjunct to other therapies in the intensive care setting [42] . Close monitoring of blood pressure is essential, since the vasodilatory effects can be delayed. At this time, we cannot recommend these agents for initial care.
Corticosteroids
Corticosteroids have a fundamental role in the stress response to infection and thus have long been trialed in the management of sepsis [43] . When steroids were used in low dose, they improved 28-day survival from sepsis [44] . New recommendations on the use of exogenous corticosteroids in adults have resulted in improved indications for their use, specifically, in the setting of catecholamine-resistant shock. These data can be extrapolated to the pediatric population, since the indications for administration of corticosteroids will depend on the presence or lack of a physiologic adrenocorticoid response regardless of age. In adults, two dose regimens have been defined arbitrarily: high dose (30 mg/kg methylprednisolone or equivalent steroid preparation given 1-4 times over 1-2 days) [45, 46] compared with low dose (recently referred to 200-300 mg/day of hydrocortisone or equivalent steroid preparation given for 5-7 days) [44, 45, [47] [48] [49] . An equivalent 'low-dose' regimen in pediatrics would be hydrocortisone 3-6 mg/kg/day in three or four divided doses, or as a continuous infusion, with the use of adult doses after 50 kg.
As the administration of corticosteroids is not without adverse events, the indication for use should be clear prior to initiation. High-dose corticosteroid is not recommended in either adults or children due to their risk of worse outcome and increased risk of infection [43, 45, 50] , and thus low-dose corticosteroids are the only regimen recommended. In addition, exogenous corticosteroids should not be administered in the treatment of sepsis in the absence of shock, unless it is part of a continuous maintenance regimen or the use of stress dose steroids is dictated by the patient's endocrine history or chronic administration of corticosteroids. The best indication for corticosteroid use is in children with catecholamineresistant shock. The best determinant of whether a patient should continue to receive steroids is based on assessment of the adrenal response to sepsis; varying opinions exist as to the best measure of adrenal response, but we recommend drawing a random cortisol level to help guide subsequent care [44, 48, 49, [51] [52] [53] 54 • ].
Identifying source of infection
In patients with sepsis, it is important to attempt to make a microbiologic diagnosis and institute appropriate therapy early. Although the focus of infection can sometimes be difficult in patients who present with sepsis, a careful history and physical exam may help narrow the suspected source. Obvious sources of infection, such as surgical wounds and indwelling foreign bodies (e.g. central lines, ventriculo-peritoneal shunts, urinary catheters, etc.) should not be ignored and cultures sent when appropriate. In addition, common sources of infection in sepsis, such as blood and urine, should be cultured.
All patients with sepsis should have blood cultures sent. In cases of immunocompromised states, intra-abdominal infections, or oral/neck infections, anaerobic cultures should be considered in addition to routine aerobic cultures. If antibiotics have already been given, blood culture should be obtained immediately prior to the next scheduled dose to minimize blood drug level. This is not guided by data, but by expert opinion [55] . Urine culture should be obtained but should not delay antibiotic therapy. A lumbar puncture should be considered in patients with signs of meningitis or neurological symptoms or signs. A lumbar puncture would ideally be done prior to antibiotics, but this may not be practical for some unstable patients.
As a result of the difficulty in obtaining sputum samples in children with pneumonia and sepsis, the predominant strategy is to provide empiric antibiotic therapy. In children who have required endotracheal intubation, however, it is important to send a sputum sample for culture and Gram stain. A pneumococcal urinary antigen has been developed but it is not widely available and the sensitivity is unclear in children [56] . If a pleural fluid or empyema is present, a diagnostic thoracentesis may be performed for fluid culture. Exudate from sites of soft tissue infection should be cultured and sent for Gram stain. If there is an abscess, a needle aspiration may be indicated for the diagnostic purposes. Unfortunately, other than the Gram stain, none of the studies described above return in sufficient time to impact initial antimicrobial selection.
Antimicrobial control of infection
Antibiotics should be started within the first hour of recognition of sepsis [57] . If there is to be a delay in obtaining a specific specimen, however, and the child is in septic shock, antibiotics should not be delayed. At a minimum, a blood culture should be obtained prior to antibiotics. In general, children should receive a broadspectrum beta-lactam antibiotic as monotherapy, or a combination of antibiotics that provide empiric coverage for pathogens expected for age and that penetrate the presumed source of infection. As of 2000, Gram-positive bacteria account for 52.1% of all pathogens causing sepsis, with Gram-negative bacteria causing 37.6% [58] . This is in contrast to prior to the year 2000, when Gramnegative bacteria predominated [58] . A third-generation cephalosporin will usually provide sufficient empiric coverage as first-line therapy. A beta-lactam antibiotic with an aminoglycoside is as efficacious but has been associated with increased nephrotoxicity. If anaerobic infection is suspected, then the addition of metronidazole or clindamycin is appropriate. For children with indwelling catheters or prosthetic materials or potential infections with methicillin-resistant Staphylococcus aureus, vancomycin should be added. Vancomycin is also indicated in the treatment of bacterial meningitis or sepsis in areas with high levels of penicillin-resistant pneumococcus, and in neutropenic patients with fever in whom coagulase-negative staphylococci and viridans streptococci are predominant pathogens [57] . If a central nervous system (CNS) infection is suspected, appropriate dosing is indicated to allow CNS penetration.
The choice of empirical antibiotic coverage therapy depends on several factors related to the patient's history, which may include previous pathogens isolated, known colonization with specific pathogens, presence of underlying disease or foreign body, and the susceptibility patterns of microorganisms of the hospital environment and patient's community [57] . Children who are at risk of neutropenia, are immunocompromised, or immunosuppressed may have microbes that require selection of additional antibiotics. Patients with known immunoglobulin deficiencies will benefit from pooled intravenous immunoglobulin.
Source control of infection
Source control encompasses all the physical measures that can be used to control a focus of infection and modify factors that promote microbial growth or impair host antimicrobial defenses. Every child who presents with sepsis should be evaluated for a source of infection amenable to source control [59] . The methods of source control predominantly include the drainage of infected fluid collections, debridement of infected tissue, and removal of devices or foreign bodies. Usually, source control will not be instituted in the pediatric emergency department except under a few circumstances; however, identifying these sources and arranging for the appropriate consulting service early in the course of a septic child is important. Examples of source control that must be initiated in the pediatric emergency department include the prompt removal of a tampon in a patient suspected of having toxic shock syndrome and early identification of necrotizing soft tissue infections so as to obtain a prompt surgical debridement.
Activated protein C
Recombinant human activated protein C has been studied in patients with septic shock and is recommended in adults at high risk of death [60, 61] . A pediatric study, however, found no improved benefit over placebo resulting in the early termination of the study [62] .
Further studies need to be performed to see if there is a subgroup of children who may benefit from this therapy.
Conclusion
Many of the recent guidelines for managing sepsis in adults should be adopted for pediatric sepsis. In the management of sepsis in the pediatric emergency department, prompt recognition of the early signs and symptoms of sepsis and shock is essential. Diagnosis of the source of infection should be attempted and appropriate antibiotics administered without delay within 1 h of presentation. Immediate measures to support circulation and counteract hypoxemia should be instituted. Volume resuscitation should be started immediately, and vasopressor support instituted if signs of shock persist despite adequate volume resuscitation. If signs of shock persist, transfusions of blood should be provided to maintain the hemoglobin of 8-10 g/dl. Frequent assessments, both clinical and laboratory, need to be performed to ensure that the interventions are effective and appropriate. Vasopressor and/or inotropic therapy should be provided based on the clinical presentation and ongoing physiologic derangements. Mixed venous SVO2 can help guide therapy. Finally, the proper transfer of care to a pediatric intensive care unit as soon as possible is essential, to ensure continued goaldirected therapies and hemodynamic monitoring.
